Schulz, F.; Hauch, U.; Ketzler-Henkel, S.; von der Heyde, E.; Koenigsmann, M.; Lauseker, M.; Schulte, N.; Germing, U.
Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR. J. Clin. Med. 2023, 12, 6569.
https://doi.org/10.3390/jcm12206569
AMA Style
Schulz F, Hauch U, Ketzler-Henkel S, von der Heyde E, Koenigsmann M, Lauseker M, Schulte N, Germing U.
Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR. Journal of Clinical Medicine. 2023; 12(20):6569.
https://doi.org/10.3390/jcm12206569
Chicago/Turabian Style
Schulz, Felicitas, Ulrich Hauch, Sandra Ketzler-Henkel, Eyck von der Heyde, Michael Koenigsmann, Michael Lauseker, Nora Schulte, and Ulrich Germing.
2023. "Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR" Journal of Clinical Medicine 12, no. 20: 6569.
https://doi.org/10.3390/jcm12206569
APA Style
Schulz, F., Hauch, U., Ketzler-Henkel, S., von der Heyde, E., Koenigsmann, M., Lauseker, M., Schulte, N., & Germing, U.
(2023). Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR. Journal of Clinical Medicine, 12(20), 6569.
https://doi.org/10.3390/jcm12206569